The Fanconi anemia group C gene product: Signaling functions in hematopoietic cells

Experimental Hematology

Volumn 29, Issue 12, 2001, Pages 1371-1381

  Fagerlie, Sara ^a,b   Lensch, M William ^b,c   Pang, Qishen ^c   Bagby, Grover C ^c  

^a PORTLAND VA MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GENE PRODUCT; PROTEIN; PROTEIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; BONE MARROW DEPRESSION; COMPLEX FORMATION; FANCONI ANEMIA; GENE THERAPY; GENETIC HETEROGENEITY; HEMATOPOIETIC CELL; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL;

ANIMALS; CELL CYCLE PROTEINS; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP A PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP C PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP PROTEINS; HEMATOPOIETIC STEM CELLS; HUMANS; NUCLEAR PROTEINS; PROTEIN ISOFORMS; PROTEINS;

ANIMALIA;

EID: 0035657297     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(01)00755-X     Document Type: Article

References (99)

1. Familiare infantile perniziosaartige anaemia (pernizioses blutbild und konstitution)
2. The emerging genetic and molecular basis of fanconi anaemia
3. Fanconi anemia; Myelodysplasia as a predictor of outcome
4. Leukemia and preleukemia in Fanconi anemia patients; A review of the literature and report of the International Fanconi Anemia Registry
5. Fanconi's anemia and malignancies
6. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents
7. Prenatal and postnatal diagnosis and carrier detection of Fanconi anemia by a cytogenetic method
8. Cytogenetic differentiation of Fanconi anemia, 'idiopathic' aplastic anemia, and Fanconi anemia heterozygotes
9. Complementation analysis in Fanconi anemia; Assignment of the reference FA-H patient to group A
10. Expression cloning of a cDNA for the major Fanconi anaemia gene, FAA
11. Cloning of cDNAs for Fanconi's anaemia by functional complementation
12. The Fanconi anaemia group G gene FANCG is identical with XRCC9
13. The Fanconi anaemia gene FANCF encodes a novel protein with homology to ROM
14. Isolation of a cDNA Representing the Fanconi Anemia Complementation Group E gene
15. Positional cloning of a novel Fanconi anemia gene, FANCD2
16. The Fanconi anemia polypeptide FACC is localized to the cytoplasm
17. Localization of Fanconi anemia C protein to the cytoplasm of mammalian cells
18. Cytoplasmic localization of a functionally active Fanconi anemia group A green fluorescent protein chimera in human 293 cells
19. The Fanconi anemia group C gene product is located in both the nucleus and cytoplasm of human cells
20. The Fanconi anaemia proteins, FAA and FAC, interact to form a nuclear complex
21. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway
22. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway
23. FANCA protein binds FANCG proteins in an intracellular complex (letter)
24. The fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG
25. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex
26. The Fanconi anemia proteins FANCA and FANCG stabilize each other and promote the nuclear accumulation of the Fanconi anemia complex
27. Resistance to mitomycin C requires direct interaction between the fanconi anemia proteins FANCA and FANCG in the nucleus through an arginine-rich domain
28. A physical complex of the Fanconi anemia proteins FANCG/XRCC9 and FANCA
29. Functional activity of the fanconi anemia protein FAA requires FAC binding and nuclear localization (In Process Citation)
30. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
31. BAP1; a novel ubiquitin hydrolase which binds to the BRCA1 ring finger and enhances BRCA1-mediated cell growth suppression
32. Suppression of apoptosis in hematopoietic factor-dependent progenitor cell lines by expression of the FAC gene
33. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1
34. Functional correction of FA-C cells with FANCC suppresses the expression of interferon γ-inducible genes
35. The Fanconi anemia group C gene product modulates apoptotic responses to tumor necrosis factor-α and Fas ligand but does not suppress expression of receptors of the tumor necrosis factor receptor superfamily
36. MxA overexpression reveals a common genetic link in four Fanconi anemia complementation groups
37. FANCC interacts with hsp70 to protect hematopoietic cells from IFNγ/TNFα-mediated cytotoxicity
38. Role of double-stranded RNA-dependent protein kinase in mediating hypersensitivity of Fanconi anemia complementation group C cells to interferon-γ, tumor necrosis factor-α, and double-stranded RNA
39. Inactivation of the Fanconi anemia group C (FAC) gene augments interferon-γ-induced apoptotic responses in hematopoietic cells
40. Overexpression of the fanconi anemia group C gene (FAC) protects hematopoietic progenitors from death induced by Fas-mediated apoptosis
41. + cells of patients with aplastic anaemia
42. Erythropoiesis in Fanconi's anemia
43. Molecular chaperone GRP94 binds to the Fanconi anemia group C protein and regulates its intracellular expression
44. The Fanconi anemia polypeptide, FAC, binds to the cyclin- dependent kinase, cdc2
45. Requirement of p34cdc2 kinase for apoptosis mediated by the Fas/APO-1 receptor and interleukin 1β-converting enzyme-related proteases
46. The promyelocytic leukemia zinc finger (PLZF) protein binds DNA in a high molecular weight complex associated with cdc2 kinase (In Process Citation)
47. A novel BTB/POZ transcriptional repressor protein interacts with the Fanconi anemia group C protein and PLZF
48. Cytoplasmic localization of FAC is essential for the correction of a pre-repair defect in Fanconi anemia group C cells
49. The Fanconi anemia complementation group C gene product; structural evidence of multifunctionality
50. The Fanconi anemia protein FANCC binds to and facilitates the activation of STAT1 by γ interferon and hematopoietic growth factors
51. Tumor necrosis factor-α and CD95 ligation suppress erythropoiesis in Fanconi anemia C gene knockout mice
52. Interferon-γ-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members
53. Biologic consequences of Stat1-independent IFN signaling
54. Stat1-independent regulation of gene expression in response to IFN-γ
55. Cytokines and JAK-STAT signaling
56. Type I interferons and T helper development
57. Autoimmune granulopoietic failure; identification of T-lymphocyte-mediated inhibition of granulopoiesis and prednisone responsiveness using in vitro techniques
58. Effect of graft-vs-host disease on hematopoiesis after bone marrow transplantation in mice
59. Circulating activated suppressor T lymphocytes in aplastic anemia
60. Tumor necrosis factor-α overproduction in Fanconi's anemia
61. α/β interferons potentiate virus-induced apoptosis through activation of the FADD/Caspase-8 death signaling pathway
62. Activation of the dsRNA-dependent protein kinase, PKR, induces apoptosis through FADD-mediated death signaling
63. Phosphorylation of eukaryotic translation initiation factor 2 mediates apoptosis in response to activation of the double-stranded RNA-dependent protein kinase
64. PKR; a sentinel kinase for cellular stress
65. Induction of apoptosis by double-stranded RNA-dependent protein kinase (PKR) involves the α subunit of eukaryotic translation initiation factor 2 and NF-κB
66. The interferon-inducible protein kinase PKR modulates the transcriptional activation of immunoglobulin κ gene
67. Interferon-induced proteins are elevated in blood samples of patients with chemically or virally induced chronic fatigue syndrome
68. Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols
69. The sensitivity of Fanconi anaemia group C cells to apoptosis induced by mitomycin C is due to oxygen radical generation, not DNA crosslinking
70. Mitomycin C and diepoxybutane action mechanisms and FANCC protein functions; further insights into the role for oxidative stress in Fanconi's anaemia phenotype
71. Cloning of the bovine and rat Fanconi anemia group C cDNA
72. Cloning and analysis of the murine Fanconi anemia group C cDNA
73. Clinical variability of fanconi anemia (type C) results from expression of an amino terminal truncated fanconi anemia complementation group C polypeptide with partial activity
74. Somatic mosaicism in Fanconi anemia; Evidence of genotypic reversion in lymphohematopoietic stem cells
75. Selective pressure as an essential force in molecular evolution of myeloid leukemic clones; a view from the window of Fanconi anemia
76. Somatic mosaicism in Fanconi anemia; Molecular basis and clinical significance
77. Spontaneous functional correction of homozygous fanconi anaemia alleles reveals novel mechanistic basis for reverse mosaicism (In Process Citation)
78. New recessive syndrome characterized by increased chromosomal breakage and several findings which overlap with Fanconi anemia
79. Translational control of viral gene expression in eukaryotes (In Process Citation)
80. The emerging role of the interferon-induced PKR protein kinase as an apoptotic effector; a new face of death?
81. Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation
82. Bone marrow failure in the Fanconi anemia group C mouse model after DNA damage
83. Assessment of mitomycin C sensitivity in Fanconi anemia complementation group C gene (Fac) knockout mouse cells
84. Mice with a targeted disruption of the Fanconi anemia homolog Fanca
85. Fanconi anemia complementation group C is required for proliferation of murine primordial germ cells
86. Germ cell defects and hematopoietic hypersensitivity to γ-interferon in mice with a targeted disruption of the Fanconi anemia C gene
87. Inactivation of Fac in mice produces inducible chromosomal instability and reduced fertility reminiscent of Fanconi anaemia
88. Stem cell factor/c-kit upregulates cyclin D3 and promotes cell cycle progression via the phosphoinositide 3-kinase/p70 S6 kinase pathway in spermatogonia
89. Expression of c-kit messenger ribonucleic acid in human oocyte and presence of soluble c-kit in follicular fluid
90. Apoptosis regulator bcl-w is essential for spermatogenesis but appears otherwise redundant
91. Treatment related leukemia in Hodgkin's disease; a multi-institution study on 75 cases
92. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in children; correlation between chromosomal abnormalities and prior therapy
93. Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure
94. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities
95. Aberrant Fanconi anaemia protein profiles in acute myeloid leukaemia cells
96. In vivo selection of wild-type hematopoietic stem cells in a murine model of Fanconi anemia